VIKTORIA-1 shows gedatolisib maintained strong PFS benefit over alpelisib in PIK3CA-mutant HR+/HER2− breast cancer, including ...
After 25 Years of Awareness, Are We Changing Minds About Lung Cancer? / cancer, Dana Reeve, Jill Feldman, Lung cancer, ...
AI Can Guide Cancer Drug Discovery, but Clinical Validation Still Matters / AI, artificial intelligence, cancer, clinical ...
What Changed in Melanoma Immunotherapy Over 20 Years? / cancer, ESMO, immune response, Melanoma, Nicholas Restifo, OncoDaily, ...
Gustave Roussy International – Egypt shared on LinkedIn: “Empowering African healthcare professionals through education, collaboration, and excellence in breast cancer care ...
Making Clinical Trials Part of Cancer Care Operations / Academic-Community Partnerships, ACCC, ASCO, cancer, Cancer Center ...
Omid Hamid Honors Jeffrey Weber’s Legacy in Cancer Immunotherapy / Adjuvant Therapy, ASCO, cancer, cancer vaccines, ESMO, ...
City of Hope / cancer, City of Hope, clinical trials, esmo 2026, ESMO26, kidney cancer, kidney cancer research, ...
Richard Stephens Reflects on the 2026 NIHR Public Health Researcher Event / cancer, Cat Pinho-Gomes, David Taylor-Robinson, ...
COCOON shows lazertinib lead-in plus simplified prophylaxis reduced grade ≥2 skin toxicity to 18% with SC amivantamab in EGFR ...
At the Community Oncology Global Congress (COGC 2026), organized by OncoDaily, Amol Akhade, Senior Consultant in Medical ...
CROWN ctDNA data link early lorlatinib progression to genomic complexity, TP53 and bypass pathways rather than new ALK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results